1163670

Clario Inc — FEI 1000263641

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 4, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol